Effects of topical ropivacaine on eicosanoids and neurotransmitters in the rectum of patients with distal ulcerative colitis

Scandinavian Journal of Gastroenterology

Volumn 37, Issue 3, 2002, Pages 325-329

  Hillingso J G ^a   Kjeldsen, J ^a   Schmidt, P T ^a   Rasmussen, T N ^a   Fischer Hansen, B ^a   Holst, J J ^a   Lauritsen, K ^a   Bukhave, K ^a   Rask Madsen, Jørgen ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Eicosanoids; Inflammation; Inflammatory bowel disease; Local anaesthetics; Neuropeptides; Ropivacaine; Ulcerative colitis

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; ICOSANOID; LEUKOTRIENE B4; LIDOCAINE; LOCAL ANESTHETIC AGENT; NEUROKININ A; NEUROPEPTIDE; NEUROTRANSMITTER; PLACEBO; PROSTAGLANDIN E2; ROPIVACAINE; SOMATOSTATIN; SUBSTANCE P; THROMBOXANE B2; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSATE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GEL; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RECTUM; RECTUM BIOPSY; RELAPSE; ULCERATIVE COLITIS;

ADMINISTRATION, RECTAL; ADULT; AGED; AGED, 80 AND OVER; AMIDES; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; BIOPSY, NEEDLE; COLITIS, ULCERATIVE; DOUBLE-BLIND METHOD; EICOSANOIDS; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NEUROPEPTIDES; PROBABILITY; RECTUM; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0036189396     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655202317284237     Document Type: Article

References (36)

1. Mediators of inflammation in chronic inflammatory bowel disease
2. Neuroimmunomodulation in inflammatory bowel disease. How far from "bench" to "bedside"
3. An analysis of the mechanism of local anaesthetic inhibition of platelet aggregation and secretion
4. Antithrombotic activity of local anaesthetics in several canine model
5. Local anaesthetics and wound healing
6. Local anaesthetic inhibition of phagocytosis and metabolism of human leucocytes
7. Effects of lysomotropic amines on human polymorphonuclear leucocyte function
8. Lidocaine inhibits granulocyte adherence and prevents granulocyte delivery to inflammatory sites
9. Inhibition of human leucocyte metabolism and random motility by local anaesthesia
10. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat
11. Lidocaine and ulcerative proctitis
12. Topical treatment of ulcerative proctitis with lidocaine
13. Lidocaine gel treatment for refractory distal ulcerative colitis
14. Ropivacaine gel in distal ulcerative colitis and proctitis - A pharmacokinetic and exploratory clinical study
15. Incidence and prevalence of ulcerative colitis and Crohn's disease in the county of Copenhagen, 1962 to 1978
16. A comparison of oral prednisolone given as a single and multiple daily doses for active proctocolitis
17. 4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis
18. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis
19. 2 in jejunal fluids and its potential diagnostic value for selecting patients with indomethacin-sensitive diarrhoea
20. 2x in gastro-intestinal fluids
21. Assays for peptide products of somatostatin gene expression
22. Substance P and neurokinin A are co-distributed and co-localized in the porcine gastrointestinal tract
23. On the accuracy of radioimmunological determination of somatostatin in plasma
24. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma
25. Pigs only produce a single form of CGRP part of which is processed to N- and C-terminal fragments
26. Effects of ropivacaine on eicosanoid release from human granulocytes and endothelial cells in vitro
27. Neuropeptides and inflammation: The role of substance P
28. Distribution and quantization of gut neuropeptides in normal intestine and inflammatory bowel disease
29. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation
30. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease
31. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease
32. Regional differences in concentrations of regulatory peptides in human colon mucosal biopsy
33. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease
34. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease
35. Somatostatin in the idiopathic inflammatory bowel diseases
36. Calcitonin gene-related peptide in inflammatory bowel disease and experimentally induced colitis